Page 10
The Willner Window Product Reference Catalog, Jan-Feb, 2013
since 1911
• Willner Chemists •
the nutritional supplement professionals
to the regular multivitamin supplement. I rec-
ommend the Willner Chemists Phyto-Tech
“Antiox Phyto Complex” (liquid filled cap-
sule) or “Antiox Phyto Blend” (dropper bottle
liquid).
On the one hand, I have provided a rec-
ommendation of what you might call a basic,
or “nucleus” nutritional supplement regimen,
suitable for almost everyone. A multivitamin,
calcium-magnesium (either separate or
included in the multivitamin), omega-3 oils,
extra vitamin D, and extra “phyto” antioxi-
dants. On the other hand, everyone is differ-
ent, and everyone has unique needs. The
challenge of decided on a multivitamin pales
when compared to getting qualified and fac-
tual guidance on the remainder of your sup-
plement requirements tailored to your
unique health, diet and medical needs. You
will not find this guidance in health food
stores. You will not find it from your multi-
level marketing salesman. You will find it at
Willner Chemists.
Don Goldberg
The above article originally appeared on the
blog, dongoldberg.com. Please visit dongold-
berg.com and leave your questions and com-
ments.
. . . continued from page 8
• Prevent the formation of new blood ves-
sels, thus preventing tumors from obtaining a
blood supply necessary for continued growth.
• Prevent tumor cells from dividing and
growing by inhibiting enzymes involved in
cell replication.
Population studies have consistently found
that soy consumption may help reduce a
woman's risk of developing breast cancer.
Clinical and experimental studies further sup-
port the benefits of soy.
New Data
In the last few years, several studies with a
total of nearly 10,000 women have found
that ingestion of soy foods do not increase
the risk of recurrence of breast cancer. In
fact, a meta-analysis of these studies found
was that increasing soy consumption was
associated with lowering the risk of recur-
rence and/or all-cause mortality even in
women currently taking tamoxifen.
Specifically, ingestion of >10 mg/day of
isoflavone was associated with a statistically
significant 25% decrease in recurrence of
breast cancer.
1
In a recent study, soy intake was assessed
in 616 women with a history of breast cancer
and these women were followed for an aver-
age of 52 months.
2
Results showed a reduc-
tion of mortality from breast cancer of 36%
in those consuming 17-29 mg/day of total
isoflavones versus those consuming <7.56
mg/day. Consuming more than 29 mg/day
did not offer any significantly greater protec-
tion unless the woman was estrogen receptor
positive (ER+). These women showed a 41%
reduced mortality to breast cancer at the
higher intake level.
Soy intake was from tofu, processed soy
products, soy milk, and whole soybeans.
Results indicated that total soy protein intake
was also of benefit. Overall, 5-year survival
rates were 62.5% for those consuming less
than 2 g/day of soy protein versus 98.6% for
those consuming more than 13 g/day.
All together, these results from this study
further support the positive effects of moder-
ate intake of soy foods in women with a his-
tory of breast cancer, especially those with
ER+.
References: 1. Nechuta SJ, Caan BJ, Chen WY, et al.
Soy food intake after diagnosis of breast cancer and sur-
vival: an in-depth analysis of combined evidence from
cohort studies of US and Chinese women. Am J Clin
Nutr. 2012;96(1):123-132. 2. Zhang YF, Kang HB, Li BL,
Zhang RM. Positive effects of soy isoflavone food on sur-
vival of breast cancer patients in China. Asian Pac J
Cancer Prev. 2012;13(2):479-482.
The above is from DoctorMurray.com, your
Natural Medicine Resource.
Go to DoctorMurray.com and sign up for Dr.
Murray’s “Weekly Fast Facts” newsletter.
Soy Shows Positive Effects in
Women with a History of Breast
Cancer
by Dr. Michael Murray
Introduction
Women who have estrogen-sensitive breast
cancer have often been advised to stay away
from soy foods and soy isoflavone supple-
ments. This recommendation was based on
studies in test tubes and in animals that
showed the isoflavone genistein may stimu-
late the growth of estrogen-receptor breast
cancer cells. Since it was not known if these
results applied to humans, it made sense for
women who have estrogen-receptor positive
breast cancer to follow this recommendation
until more information was available. That
information is now available and the new
recommendation is that soy consumption at
moderate intake should actually be encour-
aged.
Background Information
Considerable evidence from laboratory and
human studies indicates soy exerts significant
anticancer effects, particularly in hormone-
sensitive cancers such as breast and prostate
cancer. Specifically, as an anticancer agent,
soy isoflavonoids:
• Act as antioxidants.
• Reduce estrogen levels, particularly free
estrogen. (Lower levels of estrogen have been
associated with a decreased risk of breast
cancer.)